Inactive Instrument
Company American Renal Associates Holdings, Inc.
Stocks
ARA
US0292271055
Healthcare Facilities & Services
Business description: American Renal Associates Holdings, Inc.

Sales by Activity: American Renal Associates Holdings, Inc.
| Fiscal Period: December | 2019 (USD) |
|---|---|
The Ownership and Operation of Dialysis Clinics | 823M |
Geographical breakdown of sales: American Renal Associates Holdings, Inc.
| Fiscal Period: December | 2019 (USD) |
|---|---|
United States | 823M |
Executive Committee: American Renal Associates Holdings, Inc.
| Manager | Title | Age | Since |
|---|---|---|---|
David Doerr
CEO | Chief Executive Officer | 56 | 01/02/2025 |
Syed Kamal
PSD | President | 73 | 01/01/1999 |
George Attmore
DFI | Director of Finance/CFO | - | - |
Geoffrey Walker
CTO | Chief Tech/Sci/R&D Officer | - | - |
Steve Duke
CTO | Chief Tech/Sci/R&D Officer | - | - |
Company details: American Renal Associates Holdings, Inc.
American Renal Associates Holdings, Inc.
500 Cummings Center
01915, Beverly
+978 922 3080
http://www.innovativerenal.com
Other Healthcare Facilities & Services
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +2.31% | -4.52% | +12.56% | +28.96% | 109B | ||
| +0.19% | +9.18% | +10.02% | +117.05% | 105B | ||
| -1.59% | -18.64% | +53.03% | +576.52% | 46.46B | ||
| +1.52% | +8.03% | +10.16% | +105.72% | 33.1B | ||
| -0.04% | +4.67% | +41.86% | +80.90% | 30.19B | ||
| -0.49% | +4.41% | +39.96% | +94.22% | 28.57B | ||
| +0.88% | +9.08% | +49.42% | +440.81% | 23B | ||
| +0.23% | +1.42% | -17.61% | -15.87% | 19.97B | ||
| +0.52% | -1.40% | -6.52% | +30.30% | 16.76B | ||
| Average | +0.39% | +1.30% | +21.43% | +162.07% | 46B | |
| Weighted average by Cap. | +0.63% | +0.94% | +20.14% | +148.45% |
















